Polycythaemia vera (Q39428): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Policitemia vera (PV) é uma neoplasia mieloproliferativa clonal caracterizada por eritrocitose frequentemente acompanhada de leucocitose e/ou trombocitose, e um risco associado aumentado de complicações hemorrágicas e trombóticas (venoso e arterial). Mutações do exon12 JAK2 p.V617F e JAK2 (Janus quinase 2) têm sido fortemente associadas à PV. | |||
| description / en | description / en | ||
Polycythaemia vera (PV) is a clonal myeloproliferative neoplasm characterized by erythrocytosis frequently accompanied by leukocytosis, and/or thrombocytosis, and an associated increased risk of haemorrhagic and thrombotic (venous and arterial) complications. JAK2 p.V617F and JAK2 (Janus kinase 2) exon12 mutations have been strongly associated with PV. | |||
Revision as of 04:50, 13 August 2026
Polycythaemia vera (PV) is a clonal myeloproliferative neoplasm characterized by erythrocytosis frequently accompanied by leukocytosis, and/or thrombocytosis, and an associated increased risk of haemorrhagic and thrombotic (venous and arterial) complications. JAK2 p.V617F and JAK2 (Janus kinase 2) exon12 mutations have been strongly associated with PV.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2A20.4 |
||
| English | Polycythaemia vera |
Polycythaemia vera (PV) is a clonal myeloproliferative neoplasm characterized by erythrocytosis frequently accompanied by leukocytosis, and/or thrombocytosis, and an associated increased risk of haemorrhagic and thrombotic (venous and arterial) complications. JAK2 p.V617F and JAK2 (Janus kinase 2) exon12 mutations have been strongly associated with PV. |
